文献速递术前评估与围术期医学疼痛医学

5-HT3拮抗剂联合地塞米松优于单用5-HT3拮抗剂预防腹腔镜术后恶心呕吐:一项Meta分析

Combination of 5-HT3 Antagonist and Dexamethasone Is Superior to 5-HT3 Antagonist Alone for PONV Prophylaxis After Laparoscopic Surgeries: A Meta-analysis.
PubMed 文献 · Anesth Analg · 2016-01-01

该Meta分析纳入17项RCT共1402例腹腔镜手术患者,比较5-HT3拮抗剂联合地塞米松与单用5-HT3拮抗剂预防术后恶心呕吐(PONV)的效果。结果显示联合组显著降低PONV发生率(OR 0.38,95%CI 0.27-0.54;NNT=6.6)和挽救性止吐药需求(OR 0.21,99%CI 0.10-0.46;NNT=6),且联合组术后24小时疼痛评分更低,但不良反应数据不足。

要点

  • 联合地塞米松可显著降低腹腔镜术后PONV发生率(OR 0.38,NNT=6.6)。
  • 联合组挽救性止吐药需求更低(OR 0.21,NNT=6)。
  • 联合组术后24小时疼痛评分更低(WMD -0.67)。

核心结论

  • 5-HT3拮抗剂联合地塞米松预防腹腔镜术后PONV显著优于单用5-HT3拮抗剂,并可能改善术后镇痛。

研究设计与样本

  • 系统综述与Meta分析,纳入17项随机对照试验,共1402例腹腔镜手术患者。

主要发现

  • 联合组PONV发生率显著降低(OR 0.38,95%CI 0.27-0.54;NNT=6.6),研究间无统计学异质性(I=0)。
  • 联合组挽救性止吐药需求降低(OR 0.21,99%CI 0.10-0.46;NNT=6)。
  • 联合组术后24小时疼痛评分更低(WMD -0.67,99%CI -1.27至-0.08)。
  • 不良反应数据不足,未能检测出显著差异。

临床怎么用

  • 对腹腔镜手术患者,可考虑5-HT3拮抗剂联合地塞米松预防PONV,以减少恶心呕吐和挽救性止吐药需求。

局限性

  • 不良反应数据不足,无法充分评估安全性差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: 5-Hydroxytryptamine type 3 (5-HT3) receptor antagonists are the most commonly used drugs for postoperative nausea vomiting (PONV) prophylaxis. Dexamethasone is another antiemetic with proven efficacy in reducing PONV. The aim of this study was to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) to compare the combination of dexamethasone and 5-HT3 antagonist versus a 5-HT3 antagonist alone as prophylaxis of PONV in laparoscopic surgical patients. METHODS: PubMed, PubMed Central, and CENTRAL databases were searched to identify those randomized trials that compared a 5-HT3 antagonist with the 5-HT3 antagonist and dexamethasone combination for PONV prophylaxis after laparoscopic surgeries. RESULTS: Data from 17 RCTs that evaluated 1402 patients were included. Results from our meta-analysis show that the combination of dexamethasone and a 5-HT3 receptor antagonist is more effective in preventing PONV than the 5-HT3 antagonist alone (odds ratio 0.38, 95% confidence interval [CI] 0.27-0.54; number needed to treat = 6.6), with no statistical heterogeneity (I = 0) among studies. The need for rescue antiemetic is also decreased in patients receiving the combination (odds ratio 0.21, 99% CI 0.10-0.46; number needed to treat = 6), although data are insufficient to detect any significant difference in incidence of adverse effects. In addition, patients in the combination group complained of less pain after 24 hours (Weighted Mean Difference -0.67, 99% CI -1.27 to -0.08). CONCLUSION: Combination of a 5-HT3 receptor antagonist and dexamethasone is significantly more effective than 5-HT3 antagonist alone in preventing PONV after laparoscopic surgeries, with possible improvement in postoperative analgesia.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Som A, Bhattacharjee S, Maitra S, et al. Combination of 5-HT3 Antagonist and Dexamethasone Is Superior to 5-HT3 Antagonist Alone for PONV Prophylaxis After Laparoscopic Surgeries: A Meta-analysis. Anesth Analg. 2016. PMID: 27870735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。